Why statistics matter: Limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis

Journal of Investigative Dermatology

Volumn 132, Issue 9, 2012, Pages 2171-2175

  Gourraud, Pierre Antoine ^a   Le Gall, Caroline ^b   Puzenat, Eve ^c   Aubin, François ^c   Ortonne, Jean Paul ^d   Paul, Carle F ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^d UNIVERSITÉ CÔTE D'AZUR   (France)

^e UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORRELATION COEFFICIENT; HEALTH CARE PERSONNEL; HUMAN; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; SCORING SYSTEM; SIMULATION; STATISTICS;

EID: 84865343757     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.124     Document Type: Article

References (19)

1. Al-Suwaidan SN, Feldman SR (2000) Clearance is not a realistic expectation of psoriasis treatment. J Am Acad Dermatol 42:796-802
2. Ashcroft DM, Wan Po AL, Williams HC et al. (1999) Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 141:185-91
3. Berth-Jones J, Grotzinger K, Rainville C et al. (2006) A study examining interand intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment. Br J Dermatol 155:707-13
4. Exum M, Rapp S, Feldman S et al. (1996) Measuring severity of psoriasis: methodological issues. J Dermatol Treat 7:119-24
5. Fredriksson T, Pettersson U (1978) Severe psoriasis - oral therapy with a new retinoid. Dermatologica 157:238-44
6. Jensen JD, Fujita M, Dellavalle RP (2011) Validation of psoriasis clinical severity and outcome measures: searching for a gold standard. Arch Dermatol 147:95-8
7. Kirby B, Fortune DG, Bhushan M et al. (2000) The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol 142:728-32
8. Kirby B, Richards HL, Woo P et al. (2001) Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 45:72-6
9. Krueger GG, Feldman SR, Camisa C et al. (2000) Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol 43:281-5
10. Langley RG, Ellis CN (2004) Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol 51:563-9
11. Mrowietz U, Kragballe K, Nast A et al. (2011) Strategies for improving the quality of care in psoriasis with the use of treatment goals - a report on an implementation meeting. J Eur Acad Dermatol Venereol 25(Suppl 3): 1-13
12. Naldi L, Svensson A, Diepgen T et al. (2003) Randomized clinical trials for psoriasis 1977-2000: the EDEN survey. J Invest Dermatol 120:738-41
13. Nast A, Kopp IB, Augustin M et al. (2006) [S3-Guidelines for the therapy of psoriasis vulgaris]. J Dtsch Dermatol Ges 4(Suppl 2):S1-126
14. Pathirana D, Ormerod AD, Saiag P et al. (2009) European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 23(Suppl 2):1-70
15. Puzenat E, Bronsard V, Prey S et al. (2010) What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol 24:10-6
16. Spuls PI, Lecluse LL, Poulsen ML et al. (2010) How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review. J Invest Dermatol 130:933-43
17. van de Kerkhof PC (1997) The Psoriasis Area and Severity Index and alternative approaches for the assessment of severity: persisting areas of confusion. Br J Dermatol 137:661-2
18. Weisman S, Pollack CR, Gottschalk RW (2003) Psoriasis disease severity measures: comparing efficacy of treatments for severe psoriasis. J Dermatolog Treat 14:158-65
19. Windish DM, Huot SJ, Green ML (2007) Medicine residents' understanding of the biostatistics and results in the medical literature. JAMA 298:1010-22